Trusted Resources: Community Center
A Guide to Understanding MPS VI
MPS VI (Maroteaux-Lamy syndrome) is caused by a recessive gene. There is a one in four chance with every pregnancy that the child will inherit the defective gene from each carrier parent and will be affected with the disease. There is a two in three chance that unaffected brothers and sisters of MPS VI children will be carriers.
MPS VI is a mucopolysaccharide disease known as Maroteaux-Lamy Syndrome. It takes its name from two French Doctors, Dr. Maroteaux and Dr. Lamy, who first described the condition in 1963. MPS VI has a wide range of symptoms that vary in severity and can be managed and treated with enzyme replacement therapies. There is no cure for MPS VI.
BookmarkRelated Content
-
Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome): Defining and Measuring Functional Impacts in Pediatric Pati...Research about pediatric patients' persp...
-
Enzyme Replacement Therapy With Galsulfase for Mucopolysaccharidosis Type VIMucopolysaccharidosis type VI (MPS VI) o...
-
Believe in G Golf TournamentGianna, was diagnosed with Sanfilippo Sy...
-
Clinical and Event-Based Outcomes of Patients With Mucopolysaccharidosis VI Receiving Enzyme Replacement Therapy in ...The objective of this study was to descr...
-
Paul Harmatz, MDDr. Paul Harmatz is a Professor in Resid...
-
MPS and Other Similar Lysosomal DiseasesMucopolysaccharidosis (MPS) and other si...
-
H4B Boston’s Living Rooms of RareIn celebration of Rare Disease Day, H4B ...
